Trials / Completed
CompletedNCT00345774
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Short-Term Efficacy and Safety of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Epix Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 25 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to see if PRX-08066 can lower pulmonary artery pressures in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRX-08066 |
Timeline
- Start date
- 2006-06-01
- Completion
- 2007-06-01
- First posted
- 2006-06-28
- Last updated
- 2008-05-29
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00345774. Inclusion in this directory is not an endorsement.